Endovia Health Sciences, Inc.
EDVA
9 hedge funds and large institutions have $1.01M invested in Endovia Health Sciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$358K |
| 2 |
SC
Shay Capital
New York
|
+$171K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$171K |
| 4 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$148K |
| 5 |
VF
Virtu Financial
New York
|
+$79.4K |
Top Sellers
EDVA Hedge Fund Activity: Q2 2021 in Review
9 of the 5,766 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q2 2021, worth a combined $1.01M.
Buyers outnumbered sellers: 9 funds opened new EDVA positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $358K.
- 9 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $1.01M of Endovia Health Sciences, Inc. stock for Q2 2021.
- 9 funds opened new Endovia Health Sciences, Inc. positions in Q2 2021 and 0 closed out, a net change of +9 holders.
- The largest Endovia Health Sciences, Inc. buyer in Q2 2021 was FNY Investment Advisers, an estimated $358K added.
Based on aggregated 13F filings for Q2 2021.